Cetera Advisor Networks’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $33.5K | Hold |
12,500
| – | – | ﹤0.01% | 2766 |
|
|
2023
Q4 | $37.4K | Sell |
12,500
-762
| -6% | -$2.28K | ﹤0.01% | 2720 |
|
|
2023
Q3 | $13K | Hold |
13,262
| – | – | ﹤0.01% | 2679 |
|
|
2023
Q2 | $18.4K | Buy |
13,262
+337
| +3% | +$468 | ﹤0.01% | 2558 |
|
|
2023
Q1 | $20.6K | Hold |
12,925
| – | – | ﹤0.01% | 2532 |
|
|
2022
Q4 | $80.5K | Hold |
12,925
| – | – | ﹤0.01% | 2399 |
|
|
2022
Q3 | $87K | Hold |
12,925
| – | – | ﹤0.01% | 1977 |
|
|
2022
Q2 | $82K | Hold |
12,925
| – | – | ﹤0.01% | 1973 |
|
|
2022
Q1 | $60K | Hold |
12,925
| – | – | ﹤0.01% | 2009 |
|
|
2021
Q4 | $65K | Sell |
12,925
-100
| -0.8% | -$503 | ﹤0.01% | 1992 |
|
|
2021
Q3 | $157K | Buy |
13,025
+2,975
| +30% | +$35.9K | ﹤0.01% | 1846 |
|
|
2021
Q2 | $213K | Buy |
10,050
+75
| +0.8% | +$1.59K | ﹤0.01% | 1729 |
|
|
2021
Q1 | $280K | Sell |
9,975
-375
| -4% | -$10.5K | 0.01% | 1182 |
|
|
2020
Q4 | $269K | Sell |
10,350
-500
| -5% | -$13K | 0.01% | 1104 |
|
|
2020
Q3 | $403K | Sell |
10,850
-1,150
| -10% | -$42.7K | 0.01% | 795 |
|
|
2020
Q2 | $616K | Buy |
12,000
+4,753
| +66% | +$244K | 0.02% | 610 |
|
|
2020
Q1 | $228K | Buy |
7,247
+3,845
| +113% | +$121K | 0.01% | 932 |
|
|
2019
Q4 | $203K | Buy |
+3,402
| New | +$203K | 0.01% | 1150 |
|